GLPG0778

Galapagos NV · Phase 1 active Small molecule

At a glance

Generic name	GLPG0778
Sponsor	Galapagos NV
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study (PHASE1)
First-in-Human Single Ascending and Multiple Dose of GLPG0778 (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GLPG0778 CI brief — competitive landscape report
GLPG0778 updates RSS · CI watch RSS
Galapagos NV portfolio CI